2026³â 06¿ù 29ÀÏ ¿ù¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

With Company's Commitment to Safety Paramount, Velodyne Lidar Will Not Participate in Person at CES 2022

Press Conference to Be Held Virtually on January 5 at 11:45 a.m. PST
´º½ºÀÏÀÚ: 2021-12-29

SAN JOSE, CALIF.-- December 29, 2021 -- Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) will not participate in person at CES 2022 due to the surge in COVID-19 infection rates. The health and safety of employees, partners and the public are the topmost priorities for Velodyne and were the primary factors in the company’s decision.

Velodyne will still have a digital presence in CES and will host a virtual press conference on January 5 at 11:45 a.m. PST, which can be viewed live via webcast. The webcast link will be available on Velodyne’s ‘Events & Presentations’ webpage at that time. During the 45-minute press conference, CEO Dr. Ted Tewksbury will discuss how the company’s lidar sensors and software are shaping autonomous solutions in a wide range of markets. Additionally, he will share his vision for the future of lidar and what customers can expect from Velodyne in 2022 and beyond.

“At Velodyne, we stand by our vision: science in service of safety. This carries through in everything we do towards protecting a world in motion. While we were looking forward to connecting in person at CES 2022, to stay true to our commitment to safety, we’ve determined the most responsible course for the well-being of our employees, partners and the public is to forgo attending the event in person. While we will not be attending CES 2022 physically, we welcome engaging with customers and partners on how our lidar technology powers autonomous solutions that bring safety, sustainability, efficiency and privacy benefits,” said Dr. Tewksbury.



 Àüü´º½º¸ñ·ÏÀ¸·Î

HistoSonics Treats First Patients Using Edison Histotripsy System for Benign Prostatic Hyperplasia
Parse Biosciences and bit.bio Announce Landmark Alliance
ExaGrid Wins 5 Industry Awards at Network Computing Awards 2026
TestMu AI Introduces DevTools Assertions in Kane CLI, Enabling Browser-Level Validation Through Natural Language
Amazon, Netflix and Google to Capture Half of $81 Billion CTV Advertising Market by 2030
Mevion Medical Systems Partners with Tam Anh General Hospital to Introduce Advanced Proton Therapy in Vietnam
Comparative Absorption Study of Rice Bran-Derived ¡°Rice Magnesium¡± Reveals New Insights into Its Gradual, Sustained Absorption Profile

 

AI-Driven Upgrade Cycle Expected to Fuel 8% Telecom Growth in 2026
GCT Semiconductor Announces Strategic Commitment to Powering the AI-Ed...
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimil...
Twilio Recognized as a Leader in the 2026 Gartner Magic Quadrant for C...
RebuilderAI Introduces Brand-Exclusive Design-to-Manufacturing AI Agen...
Boomi and Couchbase Partner to Power Enterprise AI Agents with Trusted...
TestMu AI Expands Real Device Testing With Playwright Multi-Language a...

 


°øÁö»çÇ×
¹Ìµð¾î¿Í M• Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë A⋮⋮⋮ Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò W⋮⋮⋮ Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï B⋮ BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ...
º£³×ÀÍ ¡Õ Beneik 宝Ò¬ìÌ, À̺ñÁî eBizh æ¶币òª EZ æ¶òª
¿¡³ÊÀÌÀ¯ ¡Õ¡Õ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ ^v Alliuv ä¹备 AV ä¹êó备, ¾Ë¶ã =^= Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º ¡ÕC À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò ^ Alfrom ä¹尔ÜØ ä¹ì³ÜØ, ¿ÃÇÁ·Ò A⋮⋮ Allfrom &...

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..